BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 19215792)

  • 1. Interphase FISH in plasma cell dyscrasia: increase in abnormality detection with plasma cell enrichment.
    Pozdnyakova O; Crowley-Larsen P; Zota V; Wang SA; Miron PM
    Cancer Genet Cytogenet; 2009 Mar; 189(2):112-7. PubMed ID: 19215792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Application Value of CD138 MACS-FISH in the Genetic Diagnosis of Plasma Cell Dyscrasia].
    Mei JG; Li HQ; Cao HQ; Shao JJ; Zhai YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Oct; 24(5):1437-1442. PubMed ID: 27784371
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The success rate of interphase fluorescence in situ hybridization in plasma cell disorders can be improved using unconventional sources of plasma cells.
    Panakkal V; Rana S; Rathore S; Anshu A; Balakrishnan A; Singh C; Jandial A; Sachdeva MUS; Varma N; Lad D; Malhotra P; Sreedharanunni S
    Int J Lab Hematol; 2022 Feb; 44(1):157-162. PubMed ID: 34636141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interphase fluorescence in situ hybridization in multiple myeloma and monoclonal gammopathy of undetermined significance without and with positive plasma cell identification: analysis of 192 cases from the Region of Southern Denmark.
    Christensen JH; Abildgaard N; Plesner T; Nibe A; Nielsen O; Sørensen AG; Kerndrup GB;
    Cancer Genet Cytogenet; 2007 Apr; 174(2):89-99. PubMed ID: 17452249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interphase fluorescence in situ hybridization on selected plasma cells is superior in the detection of cytogenetic aberrations in plasma cell dyscrasia.
    Put N; Lemmens H; Wlodarska I; Konings P; Moreau Y; Hagemeijer A; Vandenberghe P; Michaux L
    Genes Chromosomes Cancer; 2010 Nov; 49(11):991-7. PubMed ID: 20662075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Several cytogenetic subclones may be identified within plasma cells from patients with monoclonal gammopathy of undetermined significance, both at diagnosis and during the indolent course of this condition.
    Zandecki M; Laï JL; Geneviève F; Bernardi F; Volle-Rémy H; Blanchet O; François M; Cosson A; Bauters F; Facon T
    Blood; 1997 Nov; 90(9):3682-90. PubMed ID: 9345053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic profiling of plasma cell disorders in a clinical setting: integration of microarray and FISH, after CD138 selection of bone marrow.
    Berry NK; Bain NL; Enjeti AK; Rowlings P
    J Clin Pathol; 2014 Jan; 67(1):66-9. PubMed ID: 23969274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cytogenetic aberrations in patients with multiple myeloma studied by interphase fluorescence in situ hybridization.
    Chen L; Li J; Xu W; Qiu H; Zhu Y; Zhang Y; Duan L; Qian S; Lu H
    Exp Oncol; 2007 Jun; 29(2):116-20. PubMed ID: 17704743
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multicolor interphase cytogenetics for the study of plasma cell dyscrasias.
    Sáez B; Martín-Subero JI; Odero MD; Prosper F; Cigudosa JC; Schoch R; Calasanz MJ; Siebert R
    Oncol Rep; 2007 Nov; 18(5):1099-106. PubMed ID: 17914559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal strategy for obtaining routine chromosome analysis by using negative fractions of CD138 enriched plasma cells.
    Ortega V; Mohamed G; Ehman W; Zhu M; Mendiola C; Velagaleti G
    Cancer Genet; 2016 Mar; 209(3):82-6. PubMed ID: 26797313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence in situ hybridization analysis of aneuploidization patterns in monoclonal gammopathy of undetermined significance versus multiple myeloma and plasma cell leukemia.
    Rasillo A; Tabernero MD; Sánchez ML; Pérez de Andrés M; Martín Ayuso M; Hernández J; Moro MJ; Fernández-Calvo J; Sayagués JM; Bortoluci A; San Miguel JF; Orfao A
    Cancer; 2003 Feb; 97(3):601-9. PubMed ID: 12548602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The progression from MGUS to smoldering myeloma and eventually to multiple myeloma involves a clonal expansion of genetically abnormal plasma cells.
    López-Corral L; Gutiérrez NC; Vidriales MB; Mateos MV; Rasillo A; García-Sanz R; Paiva B; San Miguel JF
    Clin Cancer Res; 2011 Apr; 17(7):1692-700. PubMed ID: 21325290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interphase fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia.
    Xu W; Li JY; Pan JL; Qiu HR; Shen YF; Li L; Wu YF; Xue YQ
    Int J Hematol; 2007 Jun; 85(5):430-6. PubMed ID: 17562621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of BCR/ABL gene rearrangements by interphase fluorescence in situ hybridization (FISH) in BCR/ABL+ leukemias: incidence and underlying genetic abnormalities.
    Primo D; Tabernero MD; Rasillo A; Sayagués JM; Espinosa AB; Chillón MC; Garcia-Sanz R; Gutierrez N; Giralt M; Hagemeijer A; San Miguel JF; Orfao A
    Leukemia; 2003 Jun; 17(6):1124-9. PubMed ID: 12764379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The parallel application of karyotype interphase and metaphase FISH after DSP-30/IL-2 stimulation is necessary for the investigation of chronic lymphocytic leukemia.
    Karakosta M; Manola KN
    Hematology; 2016 Oct; 21(9):526-35. PubMed ID: 27077766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive role of interphase cytogenetics for survival of patients with multiple myeloma.
    Königsberg R; Zojer N; Ackermann J; Krömer E; Kittler H; Fritz E; Kaufmann H; Nösslinger T; Riedl L; Gisslinger H; Jäger U; Simonitsch I; Heinz R; Ludwig H; Huber H; Drach J
    J Clin Oncol; 2000 Feb; 18(4):804-12. PubMed ID: 10673522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interphase FISH as a new tool in tumor pathology.
    Tibiletti MG
    Cytogenet Genome Res; 2007; 118(2-4):229-36. PubMed ID: 18000375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk stratification of plasma cell neoplasm: insights from plasma cell-specific cytoplasmic immunoglobulin fluorescence in situ hybridization (cIg FISH) vs. conventional FISH.
    Dong H; Yang HS; Jagannath S; Stephenson CF; Brenholz P; Mazumder A; Chari A
    Clin Lymphoma Myeloma Leuk; 2012 Oct; 12(5):366-74. PubMed ID: 22658896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interphase Molecular Cytogenetic Detection Rates of Chronic Lymphocytic Leukemia-Specific Aberrations Are Higher in Cultivated Cells Than in Blood or Bone Marrow Smears.
    Alhourani E; Aroutiounian R; Harutyunyan T; Glaser A; Schlie C; Pohle B; Liehr T
    J Histochem Cytochem; 2016 Aug; 64(8):495-501. PubMed ID: 27315825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
    Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
    J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.